“[Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids] [Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids]” (ドイツ語). Der Anaesthesist57 (4): 382–90. (April 2008). doi:10.1007/s00101-008-1326-x. PMID18351305.
Lutz, Mathias (November 2019). “Metamizole (Dipyrone) and the Liver: A Review of the Literature”. The Journal of Clinical Pharmacology59 (11): 1433–1442. doi:10.1002/jcph.1512. PMID31433499.
“Nichtopioidanalgetika zur perioperativen Schmerztherapie [Non-opioid analgesics for perioperative pain therapy. Risks and rational basis for use]” (ドイツ語). Der Anaesthesist53 (3): 263–80. (March 2004). doi:10.1007/s00101-003-0641-5. PMID15021958.
Nikolova, Irina; Tencheva, Jasmina; Voinikov, Julian; Petkova, Valentina; Benbasat, Niko; Danchev, Nikolai (2014). “Metamizole: A Review Profile of a Well-Known “Forgotten” Drug. Part I: Pharmaceutical and Nonclinical Profile”. Biotechnology & Biotechnological Equipment26 (6): 3329–3337. doi:10.5504/BBEQ.2012.0089. ISSN1310-2818.
“Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis”. Pharmacogenetics and Genomics25 (9): 462–4. (September 2015). doi:10.1097/FPC.0000000000000157. PMID26111152.
“[Agranulocytosis from metamizole: a potential problem for the British population]”. Revista Clinica Espanola209 (4): 176–9. (April 2009). doi:10.1016/s0014-2565(09)71310-4. PMID19457324.
Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016). “Safety of metamizole: a systematic review of the literature.”. J Clin Pharm Ther41 (5): 459–77. doi:10.1111/jcpt.12422. PMID27422768.
“Pharmacological characteristics of metamizole”. Polish Journal of Veterinary Sciences17 (1): 207–14. (2014). doi:10.2478/pjvs-2014-0030. PMID24724493.
“Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone”. Journal of Neural Transmission120 (11): 1533–8. (November 2013). doi:10.1007/s00702-013-1052-7. PMID23784345.
“Dipyrone”. Martindale: The Complete Drug Reference. Pharmaceutical Press (2013年12月13日). 2014年4月19日閲覧。
nih.gov
pubmed.ncbi.nlm.nih.gov
“[Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids] [Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids]” (ドイツ語). Der Anaesthesist57 (4): 382–90. (April 2008). doi:10.1007/s00101-008-1326-x. PMID18351305.
Lutz, Mathias (November 2019). “Metamizole (Dipyrone) and the Liver: A Review of the Literature”. The Journal of Clinical Pharmacology59 (11): 1433–1442. doi:10.1002/jcph.1512. PMID31433499.
“Nichtopioidanalgetika zur perioperativen Schmerztherapie [Non-opioid analgesics for perioperative pain therapy. Risks and rational basis for use]” (ドイツ語). Der Anaesthesist53 (3): 263–80. (March 2004). doi:10.1007/s00101-003-0641-5. PMID15021958.
“Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis”. Pharmacogenetics and Genomics25 (9): 462–4. (September 2015). doi:10.1097/FPC.0000000000000157. PMID26111152.
“[Agranulocytosis from metamizole: a potential problem for the British population]”. Revista Clinica Espanola209 (4): 176–9. (April 2009). doi:10.1016/s0014-2565(09)71310-4. PMID19457324.
Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016). “Safety of metamizole: a systematic review of the literature.”. J Clin Pharm Ther41 (5): 459–77. doi:10.1111/jcpt.12422. PMID27422768.
“Pharmacological characteristics of metamizole”. Polish Journal of Veterinary Sciences17 (1): 207–14. (2014). doi:10.2478/pjvs-2014-0030. PMID24724493.
“Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone”. Journal of Neural Transmission120 (11): 1533–8. (November 2013). doi:10.1007/s00702-013-1052-7. PMID23784345.